Take a deeper dive

5 Questions with Nuventra’s Consultants

Mark Sale, M.D.

We sat down with Mark Sale, M.D., to learn more about his experiences in drug development, favorite projects he’s worked on, and his advice for new scientists.

Mark received his MD from The Ohio State University and an MA in Biostatistics from Georgetown University. In addition to earning his two graduate degrees, he completed a Fellowship in Clinical Pharmacology at Stanford University and became an Assistant Professor of Medicine and Pharmacology at Georgetown University. In 1998, Mark joined GlaxoSmithKline and rose to the level of Global Director of Research Modeling and Simulation. In 2006, he started an independent consultancy in population PK, modeling, and simulation. Mark has extensive experience conducting complex population PK analyses across diverse therapeutic areas and is one of the pharmaceutical industry’s thought leaders in modeling and simulation.

Listen to the Interview

Devin Welty, Ph.D.

We sat down with Devin Welty, Ph.D., to learn more about his predicted changes in drug development, favorite projects and therapeutic areas he’s worked on, and his advice for new scientists.

Devin has more than 25 years of experience in preclinical and clinical pharmacology. He has extensive experience leading organizations and project teams from early discovery to approval and commercialization. Most recently, he served as the Global Head of DMPK for Shire. He has supported the successful submission of dozens of INDs, CTAs, NDAs, MAAs, and BLAs for molecules, biologics, and gene therapy therapeutics. He has extensive experience in pharmacokinetics, pharmacodynamics, systems pharmacology, and adopting model-informed approaches for candidate nomination and efficient clinical pharmacology strategy.

Listen to the Interview

Jessie Zhou, Ph.D.

Jessie Zhou

We sat down with Jessie Zhou, Ph.D., to learn more about her predicted changes in drug development, her advice for a brand new pharmacometrician, and her favorite project she’s worked on at Nuventra.

Jessie has more than 6 years of professional experience in clinical pharmacology, pharmacokinetics, and pharmacometrics. Her expertise includes designing, analyzing, and interpreting clinical PK studies and developing clinical pharmacology strategic plans. She also has experience in conducting  population PK and PK/PD analyses, authoring NDA sections and addressing responses to regulatory agencies. Jessie received her PhD in Experimental Clinical Pharmacology from the University of Minnesota Twin Cities. Before that, she received her Master of Science in Biomedical Engineering in Shanghai, China

Listen to the Interview

Betty Hussey, Pharm.D.

We sat down with Betty Hussey, Pharm.D., to learn more about her drug development experience, discuss her advice for new scientists, favorite projects, & life as a consultant.

Betty has over 30 years of extensive leadership and experience in clinical development, clinical pharmacology, and pharmacokinetics. Her work spans across many therapeutic areas and she has worked in all phases of development—from candidate selection to post-marketing commitments. Betty spent most of her career at GSK, where she held various management and team leadership roles including early development lead for a number of assets. Prior to joining Nuventra, she worked at Brickell Biotech as VP of Product Development. In her career, she has worked on numerous INDs, first-in-human trials and about a dozen approved drugs.

Listen to the Interview

Mark Bush, Ph.D.

We sat down with Mark Bush, Ph.D., to learn more about his experience in drug development, favorite projects he’s worked on, and some of his thoughts about upcoming changes in drug development.

Mark is Nuventra’s Vice President of Clinical Pharmacology & Pharmacokinetics. Dr. Bush has more than 20 years of experience in clinical pharmacology with a focus on study design and interpretation, as well as modeling and simulation. He received his Ph.D. in Pharmacokinetics from UNC-Chapel Hill. He previously served as Director of Clinical PK for GlaxoSmithKline and he also spent 3 years as an Assistant Professor of Pharmacy for Wingate University School of Pharmacy.

Listen to the Interview


More interviews coming soon…